Kevin Madden

Kevin Madden is currently the SVP of Platform Commercialization at Ginkgo Bioworks. Kevin has over 20 years of experience in the biotech industry, having served in various technical leadership roles at Ironwood Pharmaceuticals, Millennium Pharmaceuticals, and Microbia, Inc. Kevin has a Ph.D. in Biology from MIT and was a Post-Doctoral Fellow at Millennium Pharmaceuticals before joining the industry.

Kevin Madden has a PhD in Biology from Yale University and a BA in Biology from the University of Pennsylvania.

and Laura Bronner - VP, Commercial reports to Kevin Madden. They work with Chris Mellen - Chief Information Security Officer, Matthew F. McKnight - General Manager, Biosecurity, and Maura Sullivan - VP, Operations. Kevin Madden reports to Jason Kelly, Co-Founder & CEO.